Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
Executive summary of the Th ird Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
CEO Lars Fruergaard Jrgensen on Thursday acknowledged the sharp share price reaction after two consecutive late-stage trials showed underwhelming weight reduction versus the company's own targets, but said he nevertheless remained "encouraged" by the drug's weight loss profile
Thompson, C., Syddall, H., Rodin, I., Osmond, C
The study found that the combination therapy resulted in a significant mean body weight reduction of 20.4% compared to 3.0% with placebo, and was superior to both monotherapies
On the toxicity of kynurenic acid in vivo and in vitro
US$ 28.56
US$ 28.52
US$ 20.77
US$ 26.93
US$ 29.69